MEDVi QUAD is a prescription-only compounded sublingual liquid marketed by MEDVi as a four-ingredient erectile dysfunction treatment. As of July 2026 brand materials, the named actives are sildenafil, tadalafil, PT-141, and L-citrulline. It is prepared after a telehealth intake, not sold as an over-the-counter pill. This flagship review is the long-form file for MedviQuads Reviews, last verified August 2026.
If you only need a one-screen map, start on the homepage hub. If you need full review depth before spending money, stay here.
Does This Formula Work?
MEDVi QUAD may help some men because two of its ingredients, sildenafil and tadalafil, are FDA-approved PDE5 inhibitors for ED when sold as separate finished drugs. The compounded four-ingredient liquid itself has not been evaluated by the FDA as a finished product, so “it works” is an individual clinical outcome, not a labeled combination claim.
PT-141 (bremelanotide) and L-citrulline are included to broaden the story beyond blood-flow-only tablets. That design is a hypothesis about desire-pathway signaling plus vasodilation support. It is not the same as a published, adequate combination trial of this exact sublingual recipe. Marketing that cites a 10–15 minute onset should be read as brand messaging, not as a substitute for your clinician’s advice.
A useful mental model: class evidence ≠ combo evidence. PDE5 tablets have decades of labeled data. Stacking four actives into one compounded liquid creates a product that ranking affiliates describe with confidence, but regulators have not reviewed as a single NDA/ANDA finished drug. If single-agent tablets already failed for vascular or neurologic reasons, four ingredients may still fail.
Deeper notes: does it really work.
What's in the Formula?
As of July 2026, MEDVi-facing pages list sildenafil, tadalafil, PT-141, and L-citrulline. That mix replaced an earlier public formula that used vardenafil and apomorphine instead of PT-141 and L-citrulline. Confirm the label on any shipment you actually receive, because compounded recipes can change.
| Era | Named actives | Notes |
|---|---|---|
| Current (July 2026 brand pages) | Sildenafil, tadalafil, PT-141, L-citrulline | Melanocortin + nitric-oxide framing alongside two PDE5 drugs |
| Prior public formula | Sildenafil, tadalafil, vardenafil, apomorphine | Still appears on stale affiliate pages, treat as outdated unless your bottle matches |
| Named ingredient | Usual role in medicine | What “FDA-approved” does and does not mean here |
|---|---|---|
| Sildenafil | PDE5 inhibitor (Viagra class) | Approved as finished products for ED; not approval of this combo |
| Tadalafil | Longer-acting PDE5 inhibitor (Cialis class) | Approved as finished products for ED; duration of the combo is not separately labeled |
| PT-141 (bremelanotide) | Melanocortin agonist; Vyleesi is approved for HSDD in premenopausal women | Not an FDA-approved male ED combo with PDE5 drugs in this liquid |
| L-citrulline | Amino acid used as a supplement; nitric-oxide pathway interest | Not an FDA-approved ED drug as a finished product |
Do not confuse PT-141 with vardenafil (Levitra). Those are different molecules. Older affiliate articles mixed them up, including some 2026 pages that still mislabel PT-141 as “the active in Levitra.” That error alone is enough to distrust a review’s clinical hygiene.
Also do not confuse MEDVi QUAD with injectable Quad-Mix (papaverine / phentolamine / alprostadil ± atropine). Different route, different recipe, different risk profile. See ingredients and Quad-Mix ingredients.
How Does This Formula Work?
Sildenafil and tadalafil reduce PDE5 activity so genital blood flow can increase with sexual stimulation. They do not create an erection without stimulation. PT-141 acts on melanocortin pathways linked to sexual desire in its approved female HSDD product. L-citrulline is discussed as a nitric-oxide precursor in supplement literature, which is a weaker evidence tier than PDE5 drug labels.
Sublingual delivery is meant to allow absorption through oral mucosa and reduce some gut first-pass effects. That is a pharmaceutical rationale, not proof this specific compound is faster or safer than a generic tablet for you. Brand-adjacent copy often claims 10–15 minute onset and a multi-hour window influenced by tadalafil’s longer half-life. Those are mechanistic talking points, not endpoints from a public QUAD combination RCT.
How Much Does It Cost?
Brand-facing pages reviewed in 2026 listed promotional pricing near $114 per month for a 5-dose supply and about $179 per month for 10 doses, with clinician consult and shipping described as included. Those figures are seller statements, they change with promotions, and they are usually subscription billing rather than a one-time pharmacy cash price. Earlier coverage of a prior formula mentioned about $119 promotional pricing, evidence that list prices move.
| Plan (brand-stated, mid-2026) | Listed promotional price | Simple per-dose math | Usually said to include |
|---|---|---|---|
| 5-dose monthly | About $114 | About $22.80 per dose | Intake review, compounded liquid, shipping (confirm live) |
| 10-dose monthly | About $179 | About $17.90 per dose | Same basket of services (confirm live) |
| Reference / strikethrough | About $179 shown as comparison on some pages | n/a | Marketing contrast, use the charged amount |
Insurance rarely behaves like a retail Viagra claim for compounded telehealth kits. Compare annualized cost with cash generic sildenafil or tadalafil, which is often cheaper if a single ingredient is enough. Some brand materials contrast QUAD against buying four separate retail prescriptions; that comparison only matters if you would otherwise buy all four separately, most men would not.
How Much Should I Take?
Only the prescribing clinician should set dose, frequency, and whether you are even a candidate. Public blogs that invent milligram charts for this compounded liquid are not a substitute for the pharmacy label. Nitrate medicines, some blood-pressure drugs, and significant heart disease are classic PDE5 stop signs on FDA labels for sildenafil and tadalafil.
We do not publish an invented milligram table. If a page shows a precise QUAD milligram grid without citing the current official patient instructions, treat it as unverified. Read how to use and how much to take.
What Side Effects Should You Expect?
Expected class effects of PDE5 drugs include headache, flushing, nasal congestion, dyspepsia, back pain (more often discussed with tadalafil), and visual or hearing changes that need urgent care. Bremelanotide’s labeled product can cause nausea, flushing, and blood-pressure changes. Combining four actives can widen that list. This is not a complete safety review.
| Ingredient class | Often discussed effects | Stop-and-call flags |
|---|---|---|
| Sildenafil / tadalafil | Headache, flushing, dyspepsia, congestion | Chest pain, faintness, vision/hearing change, erection over 4 hours |
| PT-141 / bremelanotide | Nausea, flushing, headache | Significant blood-pressure symptoms per clinician advice |
| L-citrulline | GI discomfort in supplement literature | Unknown in this combo; report unexpected symptoms |
Full notes live on side effects. Do not start QUAD with nitrates. Seek emergency care for chest pain or an erection lasting more than four hours.
Is the Combo FDA Approved?
No. The finished compounded QUAD product has not been FDA-approved. That is true of compounded medicines generally. FDA approval of sildenafil or tadalafil tablets does not transfer to a custom 4-in-1 liquid. Any ad that implies the combination was FDA-evaluated as a drug product is the kind of implication FDA has punished in adjacent compounding ads.
Is It Legit?
MEDVi is a real telehealth brand with a public FDA warning letter in February 2026 about compounded GLP-1 marketing language, not a secret “QUAD raid.” Legitimacy still means: licensed clinicians, a licensed pharmacy on your bottle, no fake FDA badges, and a clear compounded-drug disclosure.
The three-entity structure matters: MEDVi as platform/billing, independent clinicians for prescribing decisions, and a compounding pharmacy for fulfillment. Brand copy reviewed in 2026 highlights Belmar’s 503B facility and cGMP language for at least some programs, do not assume every SKU ships from the same site without reading your label. See what pharmacy MEDVi uses.
Public complaint themes in this niche often focus on subscription billing, cancel friction, and refund disputes more than “the product is a fake supplement.” That pattern does not prove any individual claim; it does tell you what to screenshot before you enroll. Read Is MEDVi Quad legit? and reputation notes.
What Do Real Users Say?
We are not publishing star ratings or invented testimonials. As of August 2026 this site has not run a verified patient survey. Third-party Reddit threads exist and are summarized without copied quotes on Reddit reviews. Treat anonymous posts as anecdotes.
Competitor pages often paste Trustpilot or ConsumerAffairs averages for the parent brand. Those platforms are useful for spotting billing themes, but they are not a clinical efficacy dataset for the current QUAD formula, and they are not our AggregateRating. We refuse fake review schema.
Also: we found no Consumer Reports laboratory test of MEDVi QUAD as of August 2026 (captured on our Consumer Reports intent page).
How Does QUAD Compare with Viagra, Cialis, Hims, Roman, and Other Compounded Stacks?
Generic sildenafil or tadalafil through a clinic such as Hims or Roman is usually a single FDA-approved finished drug (when they dispense the generic tablet). QUAD is a compounded multi-ingredient liquid with a higher story and typically a higher monthly price. Neither model is “more approved” as a combination: tablets are approved as those tablets; QUAD is not approved as QUAD.
| Option | What you typically get | FDA posture | 2026 cost pattern | Tradeoff |
|---|---|---|---|---|
| MEDVi QUAD | Compounded 4-in-1 sublingual liquid via telehealth | Ingredients may have other approvals; combo is not an approved finished drug | ~$114–$179/mo kits | More ingredients and cost; more side-effect surface |
| Viagra / sildenafil | Single PDE5 tablet | Finished drug approval for ED at labeled doses | Often low cash / telehealth | Shorter duration than tadalafil for many; food can delay some tablets |
| Cialis / tadalafil | Single PDE5 tablet, daily or as-needed labels | Finished drug approval for ED | Often low telehealth | Longer window; still a nitrate contraindication |
| Hims / Roman-style ED | Often generic sildenafil or tadalafil; some compounded SKUs exist in the category | Depends on the exact SKU you are shipped | Often cheaper than QUAD kits | Usually simpler if one PDE5 works |
| Rugiet / multi-PDE5 troches | Compounded sublingual/buccal stacks | No as combo | Premium compounded band | Same compounding disclosure rules |
Longer comparisons: vs Viagra, vs Cialis, alternatives, telehealth comparison hub.
What Are the Pros and Cons?
| Pros | Cons |
|---|---|
| One checkout for consult plus meds in brand copy | Compounded combo is not FDA-approved as a finished drug |
| Includes longer-acting tadalafil in the recipe | Monthly kit pricing beats generic tablets for most budgets |
| Sublingual story may help some who dislike pills | PT-141 nausea risk stacked on PDE5 effects |
| Useful research target if generics failed | 2026 GLP-1 marketing letter is a trust tax on the brand |
| Formula updated mid-2026 with a clearer public ingredient list | Stale affiliate pages still push the old vardenafil/apomorphine recipe |
What Competitors Omit (Our Differentiation Checklist)
- Formula timeline: current PT-141 + L-citrulline vs prior vardenafil + apomorphine.
- Naming accuracy: PT-141 is not Levitra; L-citrulline is not a dopamine agonist story pasted from apomorphine copy.
- FDA letter scoping: letter 721455 (20 Feb 2026) is about GLP-1 marketing language, not a QUAD ban headline.
- Quad-Mix disambiguation: injections are a different product class.
- No star theater: we do not invent AggregateRating or personal-use testimonials.
- Amazon / Consumer Reports myths: dedicated “no” pages instead of fake lab scores.
Who Should Consider QUAD, and Who Should Not
Possible fit: men who already understand single-agent PDE5 options, prefer discreet telehealth, want a multi-mechanism compounded experiment under clinician oversight, and can tolerate cash-pay subscription economics.
Usually skip or slow down: nitrate users; men told not to use PDE5 drugs; anyone who has not tried a labeled generic; anyone who needs an FDA-approved finished product for insurance or risk tolerance; anyone unwilling to read cancel terms before paying; anyone shopping for an Amazon OTC bottle.
How the Onboarding Funnel Usually Looks
Competitor pages that claim to have “tested the intake” describe a long questionnaire covering erection quality, prior PDE5 use, cardiovascular history, medications, recreational drugs, and allergies, followed by a medical-review screen and a plan picker. That pattern matches standard telehealth ED funnels. What does not match medical best practice is any fixed “success probability” percentage that never changes across varied answers, a pattern some 2026 investigative coverage has criticized in adjacent MEDVi onboarding UX. Treat any percentage badge as marketing theater until a clinician actually reviews you.
Approval is not guaranteed. If a brand advertises a fee policy when you are declined, confirm that policy on the live checkout, not on an affiliate paraphrase. Related timing notes: how long approval takes.
How Long Does a Dose Last?
Duration talk usually rides on tadalafil’s longer half-life (often discussed as a multi-hour to roughly 36-hour response window for labeled tadalafil products). That does not mean the compounded liquid is labeled for a 36-hour guarantee. Onset talk usually rides on sublingual absorption and marketing’s 10–15 minute claim. Both numbers should be treated as mechanism-plus-marketing, not as combo-trial endpoints.
Dedicated pages: how long it lasts, how long to work.
Subscription Economics Beyond the Sticker Price
A 5-dose kit at about $114 looks manageable until you annualize it and compare with cash generics. A 10-dose kit at about $179 lowers per-dose math only if you actually use the doses. Unused doses after auto-renew are a common way “premium compounded” programs become expensive relative to as-needed generic tablets. If intimacy frequency is low, a smaller kit or a generic path may be the financially rational choice even when the 4-in-1 story is interesting.
Also price-check whether consult and shipping remain bundled when promotions rotate. Strikethrough “was $179” theater is not a medical fact.
Verification Methodology Used for This Review
- Primary regulatory text: FDA warning letter 721455 (20 February 2026) and FDA ingredient labels for sildenafil, tadalafil, and bremelanotide.
- Brand-facing formula and price claims dated as seller statements (August 2026 verification note on this site), cross-checked against mid-2026 secondary coverage.
- SERP competitor audit (August 2026) of roughly eight to ten ranking pages for “medvi quad review,” “the formula cost,” “does this compounded liquid work,” and “is the product legit”, used to map section patterns and catch molecule errors.
- Explicit refusals: no invented testimonials, No invented star ratings, no milligram charts not on a pharmacy label, no doctor persona.
Common Serp Themes We Covered on Purpose
Across the 2026 ranking set, nearly every page covers some mix of: plain definition, ingredient list, sublingual onset claim, monthly price, FDA/compounding disclaimer, pros/cons, who it is for, and a soft CTA. Weaker pages invent stars, mislabel PT-141 as Levitra, treat Quad-Mix injections as the same product, or turn the GLP-1 warning letter into a QUAD ban. Stronger pages separate platform vs clinician vs pharmacy and warn about subscription cancel windows. This review is written to match the strong set’s topical coverage while keeping the compliance and naming accuracy the weak set skips.
Unique additions you will not find on most thin funnels: formula timeline tables, a competitor-omit checklist, verification methodology with dated attributions, myth pages for Amazon and Consumer Reports intent, and an explicit refusal to ship fake review schema.
If the homework still checks out, use the official pricing path and keep screenshots of cancel terms.
Verdict
MEDVi QUAD is a real compounded telehealth offering, not a mystery Amazon bottle. It is a reasonable research target if single-ingredient PDE5 tablets failed and a clinician agrees a compounded combination is worth the extra uncertainty. It is a poor first step if you have not tried a labeled generic, if you take nitrates, or if you need an FDA-approved finished product for insurance or risk tolerance.
Confirm 2026 pricing, cancel windows, and the exact pharmacy label yourself. Treat onset marketing as a conversation starter with a clinician, not as trial data. If the official path still makes sense after that homework, use the conversion page, and keep screenshots of what you agreed to.
Sources Checked for This Page
- FDA warning letter MEDVi, LLC dba MEDVi, letter 721455, issued 20 February 2026, FDA.gov warning-letter database.
- MEDVi brand-facing QUAD and safety pages as they appeared in mid-2026 coverage (formula and promotional price claims), dated as seller statements on this site (August 2026).
- FDA labels for sildenafil (Viagra), tadalafil (Cialis), and bremelanotide (Vyleesi) for ingredient-level facts, not as approval of the combo.
- Secondary 2026 SERP coverage reviewed for competitor section patterns (pricing, cancel windows, formula change reporting), used for topic mapping, not as clinical proof.
Individual ingredients such as sildenafil and tadalafil are FDA-approved for other indications; the combined compounded formulation has not been evaluated by the FDA as a finished product, standard for all compounded medicines.
Enrollment reminder: confirm live checkout on the official MEDVi QUAD pricing path.